-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on Perspective Therapeutics, Lowers Price Target to $8

Benzinga·11/10/2026 12:59:50
Listen to the news
Piper Sandler analyst Biren Amin maintains Perspective Therapeutics (AMEX:CATX) with a Overweight and lowers the price target from $14 to $8.